Are You Getting Medical Care Or Just Testosterone?
Timeline
Timestamp
Topic
00:00
Dr. O’Connor asks whether men receiving testosterone from a TRT clinic are getting comprehensive medical care or simply receiving medication without management of the broader health consequences.
08:29
The first pillar of proper TRT care is determining why testosterone is low, including primary or secondary hypogonadism, obesity, sleep apnea, pituitary disease, medications, prior steroid use, chronic illness, alcohol, and other possible causes.
13:05
Dr. O’Connor moves into cardiovascular risk and explains why men on testosterone need attention to A1C, blood pressure, dyslipidemia, heart disease, and other ABCDs™ rather than focusing only on hormone levels.
23:45
The discussion expands into cardiovascular, kidney, and metabolic monitoring, including home blood pressure, coronary calcium, ApoB, Lp(a), diabetes risk, kidney disease, and the responsibility to monitor testosterone-related vascular effects.
26:05
Safety monitoring includes androgen-induced erythrocytosis, hemoglobin, hematocrit, iron studies, unnecessary phlebotomy, fertility, sleep apnea, PSA changes, and appropriate evaluation of prostate concerns.
32:20
Dr. O’Connor emphasizes long-term planning for men who may remain on TRT for decades, including heart-attack prevention, kidney health, fertility, individualized risk assessment, and sustainable testosterone dosing.
Video Summary
Men on TRT need comprehensive medical care, not just a testosterone prescription. Dr. O’Connor explains that proper testosterone care begins with understanding why a man has low testosterone and whether potentially reversible causes such as obesity, sleep apnea, medication use, chronic illness, or prior steroid exposure have been evaluated.
He then focuses on cardiovascular, kidney, and metabolic health through the ABCDs™ framework, including A1C, blood pressure, dyslipidemia, ApoB, Lp(a), coronary calcium, kidney function, and home blood-pressure monitoring. Excessive testosterone dosing can contribute to hypertension, fluid retention, erythrocytosis, and other risks that require ongoing medical oversight.
The presentation also covers iron depletion from unnecessary phlebotomy, fertility planning, PSA monitoring, sleep apnea, kidney testing, and long-term health planning. Dr. O’Connor’s central message is that a TRT clinic should help manage the health consequences and risks surrounding testosterone therapy rather than repeatedly measuring testosterone and estradiol alone.
Drug Callouts
Drug
Description
Testosterone
Testosterone is the central therapy throughout the presentation. Dr. O’Connor emphasizes that prescribing TRT creates a responsibility to evaluate why testosterone is low and to monitor blood pressure, cardiovascular risk, kidney health, metabolic health, erythrocytosis, fertility, prostate health, and other potential consequences over time.
Condition Callouts
Condition
Description
Hypogonadism
Dr. O’Connor emphasizes identifying the cause of low testosterone before treating it, including primary testicular disease, secondary causes, obesity, sleep apnea, pituitary disorders, medications, prior steroid exposure, chronic illness, and other potentially reversible factors.
Hypertension
Hypertension is repeatedly emphasized as an important risk for men on testosterone because TRT can raise blood pressure in some patients, particularly when dosing is excessive. Dr. O’Connor recommends regular home monitoring and integrating blood-pressure management into ongoing testosterone care.
Dyslipidemia
Dyslipidemia is discussed as a major cardiovascular risk that should be monitored in men on testosterone alongside ApoB, Lp(a), triglycerides, HDL, family history, and coronary calcium rather than relying only on a standard cholesterol value.
Chronic Kidney Disease
Kidney health is presented as a core part of TRT monitoring because cardiovascular, metabolic, and renal risks frequently overlap. Dr. O’Connor discusses creatinine, estimated GFR, cystatin C, muscle mass, creatine use, and the need to investigate potentially abnormal kidney results rather than dismissing them.
Androgen-Induced Erythrocytosis
Testosterone can increase hemoglobin and hematocrit through androgen-induced erythrocytosis. Dr. O’Connor emphasizes distinguishing this from polycythemia vera and monitoring iron and ferritin because repeated unnecessary phlebotomy can produce iron depletion.
Sleep Apnea
Sleep apnea is discussed both as a possible contributor to low testosterone and as an important ongoing health issue in men receiving TRT. Dr. O’Connor includes it among the conditions that comprehensive testosterone care should identify and manage rather than ignoring once treatment begins.
Key Takeaways
- Proper TRT care should begin by identifying why testosterone is low rather than simply prescribing testosterone from an abnormal laboratory result.
- Men on testosterone need ongoing monitoring of A1C, blood pressure, cardiovascular risk, dyslipidemia, kidney health, and the broader ABCDs™.
- Excessive testosterone dosing can contribute to hypertension, fluid retention, and other problems that should prompt reassessment of the regimen.
- Androgen-induced erythrocytosis should be evaluated alongside hemoglobin, hematocrit, ferritin, and iron rather than automatically managed with repeated phlebotomy.
- Fertility, PSA changes, sleep apnea, kidney function, and cardiovascular health remain important parts of medical care throughout long-term TRT.
- A TRT clinic should help manage the health risks surrounding testosterone therapy rather than repeatedly checking testosterone and estradiol alone.